GABRB1 ‐related early onset developmental and epileptic encephalopathy: Clinical trajectory and novel de novo mutation
Epileptic Disorders · 2023-12 · 25 (6) · 867-873
DOI: 10.1002/epd2.20132 ↗Kurz gefasst
Fallbericht in der Zeitschrift Epileptic Disorders, online erschienen am 07.08.2023. Verfasst von Edoardo Monfrini und 11 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Section, Department of Pathophysiology and Transplantation, Dino Ferrari Center, University of Milan, Milan, Italy. Hauptthemen laut MEDLINE: Epilepsy, Spasms, Infantile, Brain Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, Ministero della Salute.
Abstract (Originalsprache)
Developmental and epileptic encephalopathy 45 (DEE45) is a neurogenetic disorder caused by heterozygous pathogenic variants of GABRB1 , encoding the beta1 subunit of the GABA type A receptor. Only three infants with DEE45 have been reported so far, and a detailed description of the disease history of these patients is still lacking. We describe the clinical and genetic findings of a 21‐year‐old woman with DEE45 carrying a novel de novo GABRB1 mutation (c.841A>G, p.T281A). The patient presented at birth with hypotonia and focal apneic seizures evolving in a phenotype of epilepsy of infancy with migrating focal seizures that were refractory to antiseizure medications. Epileptic spasms partially responsive to steroid therapy appeared in the second year of life. Acquired microcephaly, profound mental retardation, and tetraparesis became evident with development. During childhood and adolescence, the epileptic phenotype evolved toward a Lennox–Gastaut Syndrome. Atypical absence status and clusters of tonic seizures occurred, often triggered by respiratory infections. The main strengths of this work are the identification of a novel pathogenic GABRB1 variant localized in the same transmembrane domain of a previously described mutation and the detailed description of the clinical trajectory of GABRB1‐related encephalopathy along 21 years of disease history.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuroscience Section, Department of Pathophysiology and Transplantation, Dino Ferrari Center, University of Milan, Milan, Italy.
- Neurology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Neurophysiopathology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
ORCID-Profile: Edoardo Monfrini, Vidal Yahya, Eleonora Mauri, Robertino Dilena
Förderung
- Italian Ministry of Health
- Ministero della Salute
Zitieren
APA
Monfrini, E., Borellini, L., Zirone, E., Yahya, V., Mauri, E., Molisso, M. T., Mameli, F., Ruggiero, F., Comi, G. P., Barbieri, S., Di Fonzo, A., & Dilena, R. (2023). GABRB1 ‐related early onset developmental and epileptic encephalopathy: Clinical trajectory and novel de novo mutation. Epileptic Disorders, 25(6), 867-873. https://doi.org/10.1002/epd2.20132
Vancouver
Monfrini E, Borellini L, Zirone E, Yahya V, Mauri E, Molisso MT, et al. GABRB1 ‐related early onset developmental and epileptic encephalopathy: Clinical trajectory and novel de novo mutation. Epileptic Disorders. 2023;25(6):867-873. doi:10.1002/epd2.20132
BibTeX
@article{Monfrini2023,
author = {Monfrini, Edoardo and Borellini, Linda and Zirone, Eleonora and Yahya, Vidal and Mauri, Eleonora and Molisso, Maria Takeko and Mameli, Francesca and Ruggiero, Fabiana and Comi, Giacomo Pietro and Barbieri, Sergio and Di Fonzo, Alessio and Dilena, Robertino},
title = {GABRB1 ‐related early onset developmental and epileptic encephalopathy: Clinical trajectory and novel de novo mutation},
journal = {Epileptic Disorders},
year = {2023},
volume = {25},
number = {6},
pages = {867--873},
doi = {10.1002/epd2.20132}
}
EUVIMED